Thailand removes cannabis from its list of narcotics and decriminalizes drugs for medical use
Thailand's Narcotics Control Board announced that it has removed cannabis plants from its list of narcotics (Category 5) to allow for broader use for medical purposes.
The Permanent Secretary of Public Health, Kiarttiphum Wongjit, and the Secretary General of the Food and Drug Administration, Paisan Dankhum have declared During a press briefing, the Narcotics Control Board announced that it had decided to remove all varieties of Kancha (cannabis) and Kanchong (hemp) from the list of controlled substances.
The repeal is intended to pave the way for greater access to medical cannabis, as well as for its use in the textile, cosmetics, and pharmaceutical industries. Hemp plants will be promoted as new cash crops.
Initially, only government agencies and community-based organizations that work with government agencies may cultivate cannabis and must apply for authorization from the FDA. A pilot program is currently underway. to authorize the home cultivation of medical cannabis.
Recreational use of cannabis remains illegal.
Decriminalization of Drugs for Medical and Research Use
At the same time, Thailand adopted A new regulation authorizing the sale and possession of Schedule 2 controlled substances, including cocaine, morphine, and opium. In a proclamation published in the Royal Gazette, the regulation mandated the decriminalization of these substances for medical and research purposes.
Under Thailand's Narcotics Act of 1979, the sale and possession of Schedule 2 substances are permitted only under specific conditions.
The proclamation stipulates that the possession and use of these substances will be permitted only for government organizations, licensed pharmacies, and healthcare professionals: pharmacists, veterinarians, and dentists. They may be used only for medical treatment, research, or «government services.».
In 2018, Thailand became the the first country in Southeast Asia to legalize cannabis for medical purposes.
China's Yongji Health Takes Control of Tasmanian Botanics
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
Which countries legalized medical cannabis before France?
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
South Korea is preparing to begin local production of medical cannabis to meet rising demand
In the United States, cannabis use among high school students has reached an all-time low
Medical cannabis use surges by 64 % in Denmark
Canopy Growth Enters the U.K. Market with Four Canadian Strains
CBD: Full-Spectrum Extracts Under Threat in Greece
Medical Cannabis and Back Pain: Opioid Use Has Dropped by 90 % in 10 Years
-
Cannabis and driving2 weeks agoCannabis and CBD: French Drivers Can Now Lose Their License Even Without a Positive Test Result
-
Cannabis in France3 weeks ago
Cannabis Legalization: The LFI Bill Has a Major Problem—THC
-
Cannabis in France22 hours agoWhich countries legalized medical cannabis before France?
-
Cannabis in the Netherlands2 weeks ago
One year after the launch of the Dutch cannabis experiment, the first trends are emerging
-
Cannabis in France2 weeks ago
French medical cannabis remains stalled at the Ministry of Health
-
Cannabis in Argentina1 week ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Business2 weeks ago
The United Kingdom Is Moving Closer to a Regulated CBD Market
-
Cannabis in France1 week ago
Rima Hassan: When «Drugs» Become a Political Weapon
You must be logged in to post a comment Login